Senti Biosciences's total assets for Q1 2024 were $102.19M, a decrease of -14.48% from the previous quarter. SNTI total liabilities were $46.09M for the fiscal quarter, a -12.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.